TY - JOUR
T1 - Insulin dependence of murine T‐cell lymphoma. II. Insulin‐deficient diabetic mice and mice fed low‐energy diet develop resistance to lymphoma growth
AU - Sharon, Raphael
AU - Pillemer, Graciela
AU - Ish‐Shalom, Dvorah
AU - Kalman, Rony
AU - Ziv, Ehud
AU - Berry, Elliot M.
AU - Naor, David
PY - 1993/3/12
Y1 - 1993/3/12
N2 - Physiological concentrations of insulin support the in vitro growth of LB T‐cell lymphoma. We could not detect similar insulin dependence in other tumor cell lines. This study reports that insulin also enhances the growth of LB cells in vivo. Mice treated with Streptozotocin (SZ) developed partial resistance to LB lymphoma growth and they survived longer (p < 0.0025) than non‐diabetic mice after LB‐cell inoculation. A few diabetic mice developed complete tumor resistance, manifested by total regression of the lymphoma. SZ‐treated diabetic mice reconstituted with external insulin died as fast as non‐diabetic mice when both were inoculated with the same number of LB cells. The SZ‐treated diabetic mice did not develop resistance to the growth of BCLI B‐cell leukemia, which demonstrated only a marginal proliferative response to insulin in vitro. Mice fed a low‐energy diet exhibited low insulin levels and also developed resistance to lymphoma growth (50% survival 21 days vs. 15 days; p < 0.0005), supporting the concept that insulin enhances LB T‐cell tumor development in mice.
AB - Physiological concentrations of insulin support the in vitro growth of LB T‐cell lymphoma. We could not detect similar insulin dependence in other tumor cell lines. This study reports that insulin also enhances the growth of LB cells in vivo. Mice treated with Streptozotocin (SZ) developed partial resistance to LB lymphoma growth and they survived longer (p < 0.0025) than non‐diabetic mice after LB‐cell inoculation. A few diabetic mice developed complete tumor resistance, manifested by total regression of the lymphoma. SZ‐treated diabetic mice reconstituted with external insulin died as fast as non‐diabetic mice when both were inoculated with the same number of LB cells. The SZ‐treated diabetic mice did not develop resistance to the growth of BCLI B‐cell leukemia, which demonstrated only a marginal proliferative response to insulin in vitro. Mice fed a low‐energy diet exhibited low insulin levels and also developed resistance to lymphoma growth (50% survival 21 days vs. 15 days; p < 0.0005), supporting the concept that insulin enhances LB T‐cell tumor development in mice.
UR - http://www.scopus.com/inward/record.url?scp=0027523609&partnerID=8YFLogxK
U2 - 10.1002/ijc.2910530523
DO - 10.1002/ijc.2910530523
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 8449610
AN - SCOPUS:0027523609
SN - 0020-7136
VL - 53
SP - 843
EP - 849
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 5
ER -